271 related articles for article (PubMed ID: 25217697)
1. Pyk2 promotes tumor progression in multiple myeloma.
Zhang Y; Moschetta M; Huynh D; Tai YT; Zhang Y; Zhang W; Mishima Y; Ring JE; Tam WF; Xu Q; Maiso P; Reagan M; Sahin I; Sacco A; Manier S; Aljawai Y; Glavey S; Munshi NC; Anderson KC; Pachter J; Roccaro AM; Ghobrial IM
Blood; 2014 Oct; 124(17):2675-86. PubMed ID: 25217697
[TBL] [Abstract][Full Text] [Related]
2. The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma.
Kamihara Y; Takada K; Sato T; Kawano Y; Murase K; Arihara Y; Kikuchi S; Hayasaka N; Usami M; Iyama S; Miyanishi K; Sato Y; Kobune M; Kato J
Oncotarget; 2016 Sep; 7(39):64330-64341. PubMed ID: 27602957
[TBL] [Abstract][Full Text] [Related]
3. Cooperation between c-Met and focal adhesion kinase family members in medulloblastoma and implications for therapy.
Guessous F; Yang Y; Johnson E; Marcinkiewicz L; Smith M; Zhang Y; Kofman A; Schiff D; Christensen J; Abounader R
Mol Cancer Ther; 2012 Feb; 11(2):288-97. PubMed ID: 22188814
[TBL] [Abstract][Full Text] [Related]
4. Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.
Meads MB; Fang B; Mathews L; Gemmer J; Nong L; Rosado-Lopez I; Nguyen T; Ring JE; Matsui W; MacLeod AR; Pachter JA; Hazlehurst LA; Koomen JM; Shain KH
Oncogene; 2016 May; 35(21):2723-34. PubMed ID: 26387544
[TBL] [Abstract][Full Text] [Related]
5. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
6. B cell receptor-induced phosphorylation of Pyk2 and focal adhesion kinase involves integrins and the Rap GTPases and is required for B cell spreading.
Tse KW; Dang-Lawson M; Lee RL; Vong D; Bulic A; Buckbinder L; Gold MR
J Biol Chem; 2009 Aug; 284(34):22865-77. PubMed ID: 19561089
[TBL] [Abstract][Full Text] [Related]
7. Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis.
Verma N; Müller AK; Kothari C; Panayotopoulou E; Kedan A; Selitrennik M; Mills GB; Nguyen LK; Shin S; Karn T; Holtrich U; Lev S
Cancer Res; 2017 Jan; 77(1):86-99. PubMed ID: 27793840
[TBL] [Abstract][Full Text] [Related]
8. Pyk2 inhibition promotes contractile differentiation in arterial smooth muscle.
Grossi M; Bhattachariya A; Nordström I; Turczyńska KM; Svensson D; Albinsson S; Nilsson BO; Hellstrand P
J Cell Physiol; 2017 Nov; 232(11):3088-3102. PubMed ID: 28019664
[TBL] [Abstract][Full Text] [Related]
9. Pyk2 inhibition of p53 as an adaptive and intrinsic mechanism facilitating cell proliferation and survival.
Lim ST; Miller NL; Nam JO; Chen XL; Lim Y; Schlaepfer DD
J Biol Chem; 2010 Jan; 285(3):1743-53. PubMed ID: 19880522
[TBL] [Abstract][Full Text] [Related]
10. The role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in hepatocellular carcinoma.
Geng W; Ng KT; Sun CK; Yau WL; Liu XB; Cheng Q; Poon RT; Lo CM; Man K; Fan ST
PLoS One; 2011; 6(11):e27362. PubMed ID: 22096562
[TBL] [Abstract][Full Text] [Related]
11. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
12. The tyrosine kinase pyk2 promotes migration and invasion of glioma cells.
Lipinski CA; Tran NL; Menashi E; Rohl C; Kloss J; Bay RC; Berens ME; Loftus JC
Neoplasia; 2005 May; 7(5):435-45. PubMed ID: 15967096
[TBL] [Abstract][Full Text] [Related]
13. FAK and Pyk2 activity promote TNF-α and IL-1β-mediated pro-inflammatory gene expression and vascular inflammation.
Murphy JM; Jeong K; Rodriguez YAR; Kim JH; Ahn EE; Lim SS
Sci Rep; 2019 May; 9(1):7617. PubMed ID: 31110200
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Efficacy of the Demethylation Agent Decitabine in Combination With the Protease Inhibitor Bortezomib for Treating Multiple Myeloma Through the Wnt/β-Catenin Pathway.
Jin Y; Xu L; Wu X; Feng J; Shu M; Gu H; Gao G; Zhang J; Dong B; Chen X
Oncol Res; 2019 Jun; 27(6):729-737. PubMed ID: 30837032
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Inhibition of FAK-Pyk2 Pathway Protects Against Organ Damage and Prolongs the Survival of Septic Mice.
Alves GF; Aimaretti E; Einaudi G; Mastrocola R; de Oliveira JG; Collotta D; Porchietto E; Aragno M; Cifani C; Sordi R; Thiemermann C; Fernandes D; Collino M
Front Immunol; 2022; 13():837180. PubMed ID: 35178052
[TBL] [Abstract][Full Text] [Related]
16. The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence.
Sun CK; Ng KT; Sun BS; Ho JW; Lee TK; Ng I; Poon RT; Lo CM; Liu CL; Man K; Fan ST
Br J Cancer; 2007 Jul; 97(1):50-7. PubMed ID: 17551499
[TBL] [Abstract][Full Text] [Related]
17. PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation.
Perez J; Torres RA; Rocic P; Cismowski MJ; Weber DS; Darley-Usmar VM; Lucchesi PA
Am J Physiol Cell Physiol; 2011 Jul; 301(1):C242-51. PubMed ID: 21451101
[TBL] [Abstract][Full Text] [Related]
18. FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β.
Gao C; Chen G; Kuan SF; Zhang DH; Schlaepfer DD; Hu J
Elife; 2015 Sep; 4():. PubMed ID: 26274564
[TBL] [Abstract][Full Text] [Related]
19. Novel role of proline-rich nonreceptor tyrosine kinase 2 in vascular wall remodeling after balloon injury.
Gadepalli R; Singh NK; Kundumani-Sridharan V; Heckle MR; Rao GN
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2652-61. PubMed ID: 22922962
[TBL] [Abstract][Full Text] [Related]
20. Cbl-b accelerates trypsin-induced cell detachment through ubiquitination and degradation of proline-rich tyrosine kinase 2.
Fan Y; Qu X; Ma Y; Qu J; Liu Y; Hu X
Tumour Biol; 2014 Nov; 35(11):11129-35. PubMed ID: 25099615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
